Delayed Low Pressure at Reperfusion: A New Approach for Cardioprotection
Overview
Affiliations
Objectives: The aims of this study were to evaluate whether the delayed application of low-pressure reperfusion could reduce lethal reperfusion injury and whether the inhibition of the opening of the mitochondrial permeability transition pore is involved in this protection.
Methods: Isolated rat hearts (n = 120) underwent 40 minutes of global ischemia followed by 60 minutes of reperfusion. Hearts were randomly assigned to the following groups: control, postconditioning (comprising 2 episodes of 30 seconds of ischemia and 30 seconds of reperfusion), and low-pressure reperfusion (using a reduction of perfusion pressure at 70 cm H2O for 10 minutes). In additional groups, postconditioning and low-pressure reperfusion were applied after a delay of 3, 10, and 20 minutes after the initial 40-minute ischemic insult.
Results: As expected, infarct size (triphenyltetrazolium chloride staining) and lactate dehydrogenase release were significantly reduced in low-pressure reperfusion and postconditioning versus controls (P < .01), whereas functional parameters (coronary flow, rate pressure product) were improved (P < .01). Although delaying postconditioning by more than 3 minutes resulted in a loss of protection, low-pressure reperfusion still significantly reduced infarct size when applied as late as 20 minutes after reperfusion. This delayed low-pressure reperfusion protection was associated with an improved mitochondrial respiration, lower reactive oxygen species production, and enhanced calcium retention capacity, related to inhibition of permeability transition pore opening.
Conclusions: We demonstrated for the first time that low-pressure reperfusion can reduce lethal myocardial reperfusion injury even when performed 10 to 20 minutes after the initiation of reperfusion.
Crola Da Silva C, Baetz D, Vedere M, Lo-Grasso M, Wehbi M, Chouabe C Life (Basel). 2023; 13(3).
PMID: 36983862 PMC: 10053810. DOI: 10.3390/life13030707.
Ferrera R, Vedere M, Lo-Grasso M, Augeul L, Chouabe C, Bidaux G Int J Mol Sci. 2022; 23(21).
PMID: 36361649 PMC: 9657531. DOI: 10.3390/ijms232112858.
Sezer M, Escaned J, Broyd C, Umman B, Bugra Z, Ozcan I J Am Heart Assoc. 2022; 11(10):e024172.
PMID: 35574948 PMC: 9238546. DOI: 10.1161/JAHA.121.024172.
Fischesser D, Bo B, Benton R, Su H, Jahanpanah N, Haworth K J Cardiovasc Pharmacol Ther. 2021; 26(6):504-523.
PMID: 34534022 PMC: 8960123. DOI: 10.1177/10742484211046674.
Basalay M, Davidson S, Gourine A, Yellon D Basic Res Cardiol. 2018; 113(4):25.
PMID: 29858664 PMC: 5984640. DOI: 10.1007/s00395-018-0684-z.